120 related articles for article (PubMed ID: 28256433)
1. The value of systematic contouring of the bowel for treatment plan optimization in image-guided cervical cancer high-dose-rate brachytherapy.
Damato AL; Buzurovic I; Bhagwat MS; Cormack RA; Devlin PM; Friesen S; Hansen J; Lee LJ; Manuel MM; Cho LP; O'Farrell D; Viswanathan AN
Brachytherapy; 2017; 16(3):579-585. PubMed ID: 28256433
[TBL] [Abstract][Full Text] [Related]
2. Dose-volume parameters and clinical outcome of CT-guided free-hand high-dose-rate interstitial brachytherapy for cervical cancer.
Wang Y; Ye WJ; Du LH; Li AJ; Ren YF; Cao XP
Chin J Cancer; 2012 Dec; 31(12):598-604. PubMed ID: 22640625
[TBL] [Abstract][Full Text] [Related]
3. Deformable image registration-based contour propagation yields clinically acceptable plans for MRI-based cervical cancer brachytherapy planning.
Chapman CH; Polan D; Vineberg K; Jolly S; Maturen KE; Brock KK; Prisciandaro JI
Brachytherapy; 2018; 17(2):360-367. PubMed ID: 29331573
[TBL] [Abstract][Full Text] [Related]
4. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
[TBL] [Abstract][Full Text] [Related]
5. Image-based 3D treatment planning for vaginal cylinder brachytherapy: dosimetric effects of bladder filling on organs at risk.
Hung J; Shen S; De Los Santos JF; Kim RY
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):980-5. PubMed ID: 22138458
[TBL] [Abstract][Full Text] [Related]
6. Effect of bladder distension on doses to organs at risk in Pulsed-Dose-Rate 3D image-guided adaptive brachytherapy for locally advanced cervical cancer.
Nesseler JP; Charra-Brunaud C; Salleron J; Py JF; Huertas A; Meknaci E; Courrech F; Peiffert D; Renard-Oldrini S
Brachytherapy; 2017; 16(5):976-980. PubMed ID: 28694116
[TBL] [Abstract][Full Text] [Related]
7. A novel two-step optimization method for tandem and ovoid high-dose-rate brachytherapy treatment for locally advanced cervical cancer.
Sharma M; Fields EC; Todor DA
Brachytherapy; 2015; 14(5):613-8. PubMed ID: 26092424
[TBL] [Abstract][Full Text] [Related]
8. Utrecht Interstitial Applicator Shifts and DVH Parameter Changes in 3D CT-based HDR Brachytherapy of Cervical Cancer.
Shi D; He MY; Zhao ZP; Wu N; Zhao HF; Xu ZJ; Cheng GH
Asian Pac J Cancer Prev; 2015; 16(9):3945-9. PubMed ID: 25987066
[TBL] [Abstract][Full Text] [Related]
9. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
[TBL] [Abstract][Full Text] [Related]
10. Appropriate Methodology for EBRT and HDR Intracavitary/Interstitial Brachytherapy Dose Composite and Clinical Plan Evaluation for Patients With Cervical Cancer.
Xu Z; Traughber BJ; Fredman E; Albani D; Ellis RJ; Podder TK
Pract Radiat Oncol; 2019 Nov; 9(6):e559-e571. PubMed ID: 31238167
[TBL] [Abstract][Full Text] [Related]
11. Bladder distension improves the dosimetry of organs at risk during intracavitary cervical high-dose-rate brachytherapy.
Harmon G; Chinsky B; Surucu M; Harkenrider M; Small W
Brachytherapy; 2016; 15(1):30-4. PubMed ID: 26521661
[TBL] [Abstract][Full Text] [Related]
12. Deformable image registration for cervical cancer brachytherapy dose accumulation: Organ at risk dose-volume histogram parameter reproducibility and anatomic position stability.
Flower E; Do V; Sykes J; Dempsey C; Holloway L; Summerhayes K; Thwaites DI
Brachytherapy; 2017; 16(2):387-392. PubMed ID: 28161434
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive evaluation of adaptive daily planning for cervical cancer HDR brachytherapy.
Meerschaert R; Nalichowski A; Burmeister J; Paul A; Miller S; Hu Z; Zhuang L
J Appl Clin Med Phys; 2016 Nov; 17(6):323-333. PubMed ID: 27929505
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric consequences of interobserver variability in delineating the organs at risk in gynecologic interstitial brachytherapy.
Damato AL; Townamchai K; Albert M; Bair RJ; Cormack RA; Jang J; Kovacs A; Lee LJ; Mak KS; Mirabeau-Beale KL; Mouw KW; Phillips JG; Pretz JL; Russo AL; Lewis JH; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):674-81. PubMed ID: 24803035
[TBL] [Abstract][Full Text] [Related]
15. A knowledge-based organ dose prediction tool for brachytherapy treatment planning of patients with cervical cancer.
Yusufaly TI; Kallis K; Simon A; Mayadev J; Yashar CM; Einck JP; Mell LK; Brown D; Scanderbeg D; Hild SJ; Covele B; Moore KL; Meyers SM
Brachytherapy; 2020; 19(5):624-634. PubMed ID: 32513446
[TBL] [Abstract][Full Text] [Related]
16. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
[TBL] [Abstract][Full Text] [Related]
17. Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy.
Susko M; Craciunescu O; Meltsner S; Yang Y; Steffey B; Cai J; Chino J
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1099-105. PubMed ID: 26883564
[TBL] [Abstract][Full Text] [Related]
18. Rectum and bladder spacing in cervical cancer brachytherapy using a novel injectable hydrogel compound.
Damato AL; Kassick M; Viswanathan AN
Brachytherapy; 2017; 16(5):949-955. PubMed ID: 28619385
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of offline adaptive planning techniques in image-guided brachytherapy of cervical cancer.
Liu H; Kinard J; Maurer J; Shang Q; Vanderstraeten C; Hayes L; Sintay B; Wiant D
J Appl Clin Med Phys; 2018 Nov; 19(6):316-322. PubMed ID: 30284370
[TBL] [Abstract][Full Text] [Related]
20. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.
Annede P; Dumas I; Schernberg A; Tailleur A; Fumagalli I; Bockel S; Mignot F; Kissel M; Deutsch E; Haie-Meder C; Chargari C
Brachytherapy; 2019; 18(3):370-377. PubMed ID: 30797698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
